Clinical Trial

NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical Practice

Study acronym: PRIORITY- PNH

Terminated

View on ClinicalTrials.gov →

Why the trial stopped

Sponsor decision

Summary

This is a prospective, non-interventional, multicenter study to evaluate the efficacy and safety of iptacopan in patients with PNH in real-world settings in Russia.

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2025-06-17; most recent amendment 2026-07-21.

Status change: Recruiting → Terminated 2026-04-07

Status change: Not Yet Recruiting → Recruiting 2025-08-01

Trial Details

NCT Number	NCT07036718
Lead Sponsor	Novartis Pharmaceuticals
Conditions	Paroxysmal Nocturnal Hemoglobinuria
Enrollment	6 participants
Start Date	2025-07-29
Primary Completion	2025-12-25 (estimated)
Study Completion	2025-12-25 (estimated)
Updated on ClinicalTrials.gov	2026-07-22